8V34 image
Deposition Date 2023-11-26
Release Date 2024-04-03
Last Version Date 2024-04-03
Entry Detail
PDB ID:
8V34
Keywords:
Title:
Crystal structure of S. aureus TarK N-terminal domain
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.28
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CDP-glycerol glycerophosphotransferase family protein
Chain IDs:A (auth: B), B (auth: A), C, D, E, F, G, H, I, J
Chain Length:178
Number of Molecules:10
Biological Source:Staphylococcus aureus
Ligand Molecules
Primary Citation
Cryo-EM analysis of S. aureus TarL, a polymerase in wall teichoic acid biogenesis central to virulence and antibiotic resistance.
Sci Adv 10 eadj3864 eadj3864 (2024)
PMID: 38416829 DOI: 10.1126/sciadv.adj3864

Abstact

Wall teichoic acid (WTA), a covalent adduct of Gram-positive bacterial cell wall peptidoglycan, contributes directly to virulence and antibiotic resistance in pathogenic species. Polymerization of the Staphylococcus aureus WTA ribitol-phosphate chain is catalyzed by TarL, a member of the largely uncharacterized TagF-like family of membrane-associated enzymes. We report the cryo-electron microscopy structure of TarL, showing a tetramer that forms an extensive membrane-binding platform of monotopic helices. TarL is composed of an amino-terminal immunoglobulin-like domain and a carboxyl-terminal glycosyltransferase-B domain for ribitol-phosphate polymerization. The active site of the latter is complexed to donor substrate cytidine diphosphate-ribitol, providing mechanistic insights into the catalyzed phosphotransfer reaction. Furthermore, the active site is surrounded by electropositive residues that serve to retain the lipid-linked acceptor for polymerization. Our data advance general insight into the architecture and membrane association of the still poorly characterized monotopic membrane protein class and present molecular details of ribitol-phosphate polymerization that may aid in the design of new antimicrobials.

Legend

Protein

Chemical

Disease

Primary Citation of related structures